$80,000 of SYNCHRONY FINANCIAL lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Assist on corporate tax matters including clarifications with respect to the Tax Cuts and Jobs Act of 2017, including repeal of the net operating loss carryback."
You can find more data on corporate lobbying on Quiver Quantitative.
SYF Insider Trading Activity
SYF insiders have traded $SYF stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $SYF stock by insiders over the last 6 months:
- JONATHAN S MOTHNER (See remarks) has made 0 purchases and 2 sales selling 32,000 shares for an estimated $2,329,600.
- JEFFREY G NAYLOR has made 0 purchases and 2 sales selling 20,000 shares for an estimated $1,375,000.
- CURTIS HOWSE (See remarks) sold 12,086 shares for an estimated $894,605
- BRIAN J. SR. WENZEL (See remarks) sold 8,514 shares for an estimated $595,980
- ARTHUR W JR COVIELLO sold 8,000 shares for an estimated $591,440
- DARRELL OWENS (See remarks) has made 0 purchases and 2 sales selling 3,589 shares for an estimated $262,015.
- COURTNEY GENTLEMAN (See remarks) sold 709 shares for an estimated $48,176
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SYF Hedge Fund Activity
We have seen 447 institutional investors add shares of SYF stock to their portfolio, and 398 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 5,044,010 shares (+86.4%) to their portfolio in Q3 2025, for an estimated $358,376,910
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 3,226,563 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $229,247,301
- GOLDMAN SACHS GROUP INC added 2,147,943 shares (+46.8%) to their portfolio in Q3 2025, for an estimated $152,611,350
- BLACKROCK, INC. removed 1,926,665 shares (-5.5%) from their portfolio in Q3 2025, for an estimated $136,889,548
- AUSTRALIANSUPER PTY LTD removed 1,591,378 shares (-54.9%) from their portfolio in Q3 2025, for an estimated $113,067,406
- VANGUARD GROUP INC removed 1,487,951 shares (-3.1%) from their portfolio in Q3 2025, for an estimated $105,718,918
- ASSETMARK, INC added 1,416,909 shares (+48.3%) to their portfolio in Q3 2025, for an estimated $100,671,384
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SYF Analyst Ratings
Wall Street analysts have issued reports on $SYF in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 01/08/2026
- Barclays issued a "Overweight" rating on 01/06/2026
- BTIG issued a "Buy" rating on 10/16/2025
- Wells Fargo issued a "Overweight" rating on 10/16/2025
- HSBC issued a "Buy" rating on 10/10/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 10/01/2025
- Evercore ISI Group issued a "Outperform" rating on 09/30/2025
To track analyst ratings and price targets for SYF, check out Quiver Quantitative's $SYF forecast page.
SYF Price Targets
Multiple analysts have issued price targets for $SYF recently. We have seen 16 analysts offer price targets for $SYF in the last 6 months, with a median target of $87.0.
Here are some recent targets:
- Richard Shane from JP Morgan set a target price of $86.0 on 01/12/2026
- Moshe Orenbuch from TD Cowen set a target price of $100.0 on 01/08/2026
- Terry Ma from Barclays set a target price of $101.0 on 01/06/2026
- Donald Fandetti from Wells Fargo set a target price of $100.0 on 01/05/2026
- Sanjay Sakhrani from Keefe, Bruyette & Woods set a target price of $98.0 on 01/02/2026
- Brian Foran from Truist Securities set a target price of $92.0 on 12/22/2025
- Darrin Peller from Wolfe Research set a target price of $92.0 on 12/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.